nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—HTR6—Alzheimer's disease	0.188	0.514	CbGaD
Aripiprazole—HTR3A—Memantine—Alzheimer's disease	0.119	0.388	CbGbCtD
Aripiprazole—SLC6A4—Alzheimer's disease	0.0721	0.197	CbGaD
Aripiprazole—HTR2A—Donepezil—Alzheimer's disease	0.0557	0.182	CbGbCtD
Aripiprazole—HTR2A—Alzheimer's disease	0.0554	0.151	CbGaD
Aripiprazole—CYP2D6—Alzheimer's disease	0.0507	0.138	CbGaD
Aripiprazole—DRD2—Memantine—Alzheimer's disease	0.0445	0.145	CbGbCtD
Aripiprazole—CYP2D6—Rivastigmine—Alzheimer's disease	0.0232	0.0755	CbGbCtD
Aripiprazole—CYP2D6—Donepezil—Alzheimer's disease	0.0185	0.0604	CbGbCtD
Aripiprazole—CYP3A4—Rivastigmine—Alzheimer's disease	0.0147	0.048	CbGbCtD
Aripiprazole—CYP2D6—Galantamine—Alzheimer's disease	0.0119	0.0389	CbGbCtD
Aripiprazole—CYP3A4—Donepezil—Alzheimer's disease	0.0118	0.0384	CbGbCtD
Aripiprazole—CYP3A4—Galantamine—Alzheimer's disease	0.00759	0.0247	CbGbCtD
Aripiprazole—HTR2C—choroid plexus—Alzheimer's disease	0.00467	0.0733	CbGeAlD
Aripiprazole—DRD3—telencephalic ventricle—Alzheimer's disease	0.00246	0.0386	CbGeAlD
Aripiprazole—HTR2A—choroid plexus—Alzheimer's disease	0.00234	0.0368	CbGeAlD
Aripiprazole—HTR7—locus ceruleus—Alzheimer's disease	0.00232	0.0364	CbGeAlD
Aripiprazole—DRD1—telencephalic ventricle—Alzheimer's disease	0.00176	0.0276	CbGeAlD
Aripiprazole—HTR2A—locus ceruleus—Alzheimer's disease	0.00145	0.0227	CbGeAlD
Aripiprazole—HTR1B—telencephalic ventricle—Alzheimer's disease	0.00143	0.0224	CbGeAlD
Aripiprazole—HTR1D—telencephalic ventricle—Alzheimer's disease	0.00138	0.0217	CbGeAlD
Aripiprazole—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00137	0.0215	CbGeAlD
Aripiprazole—HTR2A—cerebellar cortex—Alzheimer's disease	0.00118	0.0185	CbGeAlD
Aripiprazole—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00115	0.0181	CbGeAlD
Aripiprazole—HTR7—telencephalic ventricle—Alzheimer's disease	0.0011	0.0173	CbGeAlD
Aripiprazole—DRD2—telencephalic ventricle—Alzheimer's disease	0.00104	0.0163	CbGeAlD
Aripiprazole—HTR1E—forebrain—Alzheimer's disease	0.000788	0.0124	CbGeAlD
Aripiprazole—HTR1E—telencephalon—Alzheimer's disease	0.000725	0.0114	CbGeAlD
Aripiprazole—HTR1B—blood vessel—Alzheimer's disease	0.000707	0.0111	CbGeAlD
Aripiprazole—HTR2A—telencephalic ventricle—Alzheimer's disease	0.000687	0.0108	CbGeAlD
Aripiprazole—HTR1D—blood vessel—Alzheimer's disease	0.000684	0.0107	CbGeAlD
Aripiprazole—HTR6—forebrain—Alzheimer's disease	0.000619	0.0097	CbGeAlD
Aripiprazole—DRD5—forebrain—Alzheimer's disease	0.000602	0.00944	CbGeAlD
Aripiprazole—HTR6—telencephalon—Alzheimer's disease	0.000569	0.00892	CbGeAlD
Aripiprazole—DRD5—telencephalon—Alzheimer's disease	0.000554	0.00868	CbGeAlD
Aripiprazole—HTR7—blood vessel—Alzheimer's disease	0.000545	0.00855	CbGeAlD
Aripiprazole—H1F0—embryo—Alzheimer's disease	0.000527	0.00826	CbGeAlD
Aripiprazole—H1F0—forebrain—Alzheimer's disease	0.000466	0.00731	CbGeAlD
Aripiprazole—DRD1—forebrain—Alzheimer's disease	0.00046	0.00722	CbGeAlD
Aripiprazole—Vilazodone—SLC6A4—Alzheimer's disease	0.000449	0.134	CrCbGaD
Aripiprazole—Ziprasidone—HTR6—Alzheimer's disease	0.000445	0.132	CrCbGaD
Aripiprazole—HTR3A—forebrain—Alzheimer's disease	0.000444	0.00697	CbGeAlD
Aripiprazole—H1F0—telencephalon—Alzheimer's disease	0.000428	0.00672	CbGeAlD
Aripiprazole—HTR1E—nervous system—Alzheimer's disease	0.000428	0.00671	CbGeAlD
Aripiprazole—DRD1—telencephalon—Alzheimer's disease	0.000423	0.00664	CbGeAlD
Aripiprazole—HTR1E—central nervous system—Alzheimer's disease	0.000412	0.00646	CbGeAlD
Aripiprazole—HTR3A—telencephalon—Alzheimer's disease	0.000409	0.00641	CbGeAlD
Aripiprazole—DRD4—brain—Alzheimer's disease	0.000379	0.00595	CbGeAlD
Aripiprazole—CHRM4—nervous system—Alzheimer's disease	0.000375	0.00588	CbGeAlD
Aripiprazole—HTR1B—forebrain—Alzheimer's disease	0.000373	0.00585	CbGeAlD
Aripiprazole—Cilostazol—CYP2D6—Alzheimer's disease	0.000371	0.111	CrCbGaD
Aripiprazole—CHRM2—forebrain—Alzheimer's disease	0.000371	0.00582	CbGeAlD
Aripiprazole—CHRM4—central nervous system—Alzheimer's disease	0.000361	0.00567	CbGeAlD
Aripiprazole—HTR1D—forebrain—Alzheimer's disease	0.000361	0.00566	CbGeAlD
Aripiprazole—HTR2C—forebrain—Alzheimer's disease	0.000357	0.00561	CbGeAlD
Aripiprazole—ADRB1—forebrain—Alzheimer's disease	0.000351	0.0055	CbGeAlD
Aripiprazole—DRD3—nervous system—Alzheimer's disease	0.000349	0.00547	CbGeAlD
Aripiprazole—HTR1B—telencephalon—Alzheimer's disease	0.000343	0.00538	CbGeAlD
Aripiprazole—CHRM2—telencephalon—Alzheimer's disease	0.000341	0.00535	CbGeAlD
Aripiprazole—HTR2A—blood vessel—Alzheimer's disease	0.00034	0.00533	CbGeAlD
Aripiprazole—SLC6A4—forebrain—Alzheimer's disease	0.000339	0.00531	CbGeAlD
Aripiprazole—CHRM1—forebrain—Alzheimer's disease	0.000338	0.00529	CbGeAlD
Aripiprazole—DRD3—central nervous system—Alzheimer's disease	0.000336	0.00527	CbGeAlD
Aripiprazole—HTR6—nervous system—Alzheimer's disease	0.000336	0.00527	CbGeAlD
Aripiprazole—HTR2B—forebrain—Alzheimer's disease	0.000336	0.00527	CbGeAlD
Aripiprazole—HTR1D—telencephalon—Alzheimer's disease	0.000332	0.00521	CbGeAlD
Aripiprazole—HTR2C—telencephalon—Alzheimer's disease	0.000329	0.00515	CbGeAlD
Aripiprazole—HTR1E—brain—Alzheimer's disease	0.000327	0.00513	CbGeAlD
Aripiprazole—DRD5—nervous system—Alzheimer's disease	0.000327	0.00513	CbGeAlD
Aripiprazole—HTR6—central nervous system—Alzheimer's disease	0.000323	0.00507	CbGeAlD
Aripiprazole—ADRB1—telencephalon—Alzheimer's disease	0.000323	0.00506	CbGeAlD
Aripiprazole—Vilazodone—CYP2D6—Alzheimer's disease	0.000316	0.0941	CrCbGaD
Aripiprazole—DRD5—central nervous system—Alzheimer's disease	0.000315	0.00494	CbGeAlD
Aripiprazole—SLC6A4—telencephalon—Alzheimer's disease	0.000312	0.00489	CbGeAlD
Aripiprazole—CHRM1—telencephalon—Alzheimer's disease	0.00031	0.00487	CbGeAlD
Aripiprazole—HTR2B—telencephalon—Alzheimer's disease	0.000309	0.00484	CbGeAlD
Aripiprazole—CHRM3—forebrain—Alzheimer's disease	0.000302	0.00474	CbGeAlD
Aripiprazole—HTR1A—forebrain—Alzheimer's disease	0.000301	0.00472	CbGeAlD
Aripiprazole—CHRM5—nervous system—Alzheimer's disease	0.000293	0.0046	CbGeAlD
Aripiprazole—HTR7—forebrain—Alzheimer's disease	0.000288	0.00451	CbGeAlD
Aripiprazole—CHRM4—brain—Alzheimer's disease	0.000287	0.0045	CbGeAlD
Aripiprazole—CHRM5—central nervous system—Alzheimer's disease	0.000282	0.00443	CbGeAlD
Aripiprazole—CHRM3—telencephalon—Alzheimer's disease	0.000278	0.00436	CbGeAlD
Aripiprazole—ADRA1A—forebrain—Alzheimer's disease	0.000277	0.00435	CbGeAlD
Aripiprazole—HTR1A—telencephalon—Alzheimer's disease	0.000277	0.00434	CbGeAlD
Aripiprazole—DRD2—forebrain—Alzheimer's disease	0.000272	0.00426	CbGeAlD
Aripiprazole—ADRA1B—nervous system—Alzheimer's disease	0.000268	0.0042	CbGeAlD
Aripiprazole—KCNH2—forebrain—Alzheimer's disease	0.000268	0.0042	CbGeAlD
Aripiprazole—DRD3—brain—Alzheimer's disease	0.000267	0.00418	CbGeAlD
Aripiprazole—HTR7—telencephalon—Alzheimer's disease	0.000264	0.00415	CbGeAlD
Aripiprazole—ADRA1B—central nervous system—Alzheimer's disease	0.000258	0.00405	CbGeAlD
Aripiprazole—HTR6—brain—Alzheimer's disease	0.000257	0.00403	CbGeAlD
Aripiprazole—ADRA1A—telencephalon—Alzheimer's disease	0.000255	0.004	CbGeAlD
Aripiprazole—H1F0—nervous system—Alzheimer's disease	0.000253	0.00397	CbGeAlD
Aripiprazole—DRD2—telencephalon—Alzheimer's disease	0.00025	0.00392	CbGeAlD
Aripiprazole—DRD5—brain—Alzheimer's disease	0.00025	0.00392	CbGeAlD
Aripiprazole—DRD1—nervous system—Alzheimer's disease	0.00025	0.00392	CbGeAlD
Aripiprazole—KCNH2—telencephalon—Alzheimer's disease	0.000246	0.00386	CbGeAlD
Aripiprazole—Perphenazine—CALM1—Alzheimer's disease	0.000245	0.0731	CrCbGaD
Aripiprazole—H1F0—central nervous system—Alzheimer's disease	0.000244	0.00382	CbGeAlD
Aripiprazole—ADRA2C—telencephalon—Alzheimer's disease	0.000243	0.00381	CbGeAlD
Aripiprazole—HTR3A—nervous system—Alzheimer's disease	0.000241	0.00378	CbGeAlD
Aripiprazole—DRD1—central nervous system—Alzheimer's disease	0.00024	0.00377	CbGeAlD
Aripiprazole—H1F0—cerebellum—Alzheimer's disease	0.000238	0.00373	CbGeAlD
Aripiprazole—HTR3A—central nervous system—Alzheimer's disease	0.000232	0.00364	CbGeAlD
Aripiprazole—CHRM5—brain—Alzheimer's disease	0.000224	0.00352	CbGeAlD
Aripiprazole—ABCB1—blood vessel—Alzheimer's disease	0.000223	0.00349	CbGeAlD
Aripiprazole—Perphenazine—HTR6—Alzheimer's disease	0.000221	0.066	CrCbGaD
Aripiprazole—HRH1—forebrain—Alzheimer's disease	0.000215	0.00337	CbGeAlD
Aripiprazole—ADRA2A—forebrain—Alzheimer's disease	0.000211	0.00331	CbGeAlD
Aripiprazole—ADRA1B—brain—Alzheimer's disease	0.000205	0.00321	CbGeAlD
Aripiprazole—HTR2A—embryo—Alzheimer's disease	0.000203	0.00318	CbGeAlD
Aripiprazole—HTR1B—nervous system—Alzheimer's disease	0.000202	0.00317	CbGeAlD
Aripiprazole—CHRM2—nervous system—Alzheimer's disease	0.000201	0.00316	CbGeAlD
Aripiprazole—HRH1—telencephalon—Alzheimer's disease	0.000197	0.0031	CbGeAlD
Aripiprazole—HTR1D—nervous system—Alzheimer's disease	0.000196	0.00307	CbGeAlD
Aripiprazole—HTR1B—central nervous system—Alzheimer's disease	0.000195	0.00306	CbGeAlD
Aripiprazole—HTR2C—nervous system—Alzheimer's disease	0.000194	0.00304	CbGeAlD
Aripiprazole—ADRA2A—telencephalon—Alzheimer's disease	0.000194	0.00304	CbGeAlD
Aripiprazole—CHRM2—central nervous system—Alzheimer's disease	0.000194	0.00304	CbGeAlD
Aripiprazole—H1F0—brain—Alzheimer's disease	0.000193	0.00303	CbGeAlD
Aripiprazole—DRD1—brain—Alzheimer's disease	0.000191	0.00299	CbGeAlD
Aripiprazole—ADRB1—nervous system—Alzheimer's disease	0.00019	0.00299	CbGeAlD
Aripiprazole—HTR1D—central nervous system—Alzheimer's disease	0.000189	0.00296	CbGeAlD
Aripiprazole—HTR2C—central nervous system—Alzheimer's disease	0.000187	0.00293	CbGeAlD
Aripiprazole—HTR3A—brain—Alzheimer's disease	0.000184	0.00289	CbGeAlD
Aripiprazole—SLC6A4—nervous system—Alzheimer's disease	0.000184	0.00288	CbGeAlD
Aripiprazole—ADRB1—central nervous system—Alzheimer's disease	0.000183	0.00287	CbGeAlD
Aripiprazole—CHRM1—nervous system—Alzheimer's disease	0.000183	0.00287	CbGeAlD
Aripiprazole—HTR2B—nervous system—Alzheimer's disease	0.000182	0.00286	CbGeAlD
Aripiprazole—HTR2A—forebrain—Alzheimer's disease	0.000179	0.00281	CbGeAlD
Aripiprazole—SLC6A4—central nervous system—Alzheimer's disease	0.000177	0.00278	CbGeAlD
Aripiprazole—CHRM1—central nervous system—Alzheimer's disease	0.000176	0.00277	CbGeAlD
Aripiprazole—HTR2B—central nervous system—Alzheimer's disease	0.000175	0.00275	CbGeAlD
Aripiprazole—Ziprasidone—SLC6A4—Alzheimer's disease	0.00017	0.0507	CrCbGaD
Aripiprazole—HTR2A—telencephalon—Alzheimer's disease	0.000165	0.00259	CbGeAlD
Aripiprazole—CHRM3—nervous system—Alzheimer's disease	0.000164	0.00257	CbGeAlD
Aripiprazole—CYP2D6—forebrain—Alzheimer's disease	0.000163	0.00256	CbGeAlD
Aripiprazole—HTR1A—nervous system—Alzheimer's disease	0.000163	0.00256	CbGeAlD
Aripiprazole—CHRM3—central nervous system—Alzheimer's disease	0.000158	0.00248	CbGeAlD
Aripiprazole—HTR1A—central nervous system—Alzheimer's disease	0.000157	0.00247	CbGeAlD
Aripiprazole—HTR7—nervous system—Alzheimer's disease	0.000156	0.00245	CbGeAlD
Aripiprazole—HTR1B—brain—Alzheimer's disease	0.000155	0.00243	CbGeAlD
Aripiprazole—CHRM2—brain—Alzheimer's disease	0.000154	0.00241	CbGeAlD
Aripiprazole—HTR1A—cerebellum—Alzheimer's disease	0.000154	0.00241	CbGeAlD
Aripiprazole—ADRA1A—nervous system—Alzheimer's disease	0.000151	0.00236	CbGeAlD
Aripiprazole—HTR7—central nervous system—Alzheimer's disease	0.00015	0.00236	CbGeAlD
Aripiprazole—CYP2D6—telencephalon—Alzheimer's disease	0.00015	0.00236	CbGeAlD
Aripiprazole—HTR1D—brain—Alzheimer's disease	0.00015	0.00235	CbGeAlD
Aripiprazole—HTR2C—brain—Alzheimer's disease	0.000148	0.00233	CbGeAlD
Aripiprazole—DRD2—nervous system—Alzheimer's disease	0.000148	0.00231	CbGeAlD
Aripiprazole—HTR7—cerebellum—Alzheimer's disease	0.000147	0.0023	CbGeAlD
Aripiprazole—ADRB1—brain—Alzheimer's disease	0.000146	0.00228	CbGeAlD
Aripiprazole—KCNH2—nervous system—Alzheimer's disease	0.000145	0.00228	CbGeAlD
Aripiprazole—ADRA1A—central nervous system—Alzheimer's disease	0.000145	0.00227	CbGeAlD
Aripiprazole—ADRA2C—nervous system—Alzheimer's disease	0.000143	0.00225	CbGeAlD
Aripiprazole—Nefazodone—SLC6A4—Alzheimer's disease	0.000143	0.0426	CrCbGaD
Aripiprazole—DRD2—central nervous system—Alzheimer's disease	0.000142	0.00223	CbGeAlD
Aripiprazole—ADRA1A—cerebellum—Alzheimer's disease	0.000142	0.00222	CbGeAlD
Aripiprazole—SLC6A4—brain—Alzheimer's disease	0.000141	0.0022	CbGeAlD
Aripiprazole—CHRM1—brain—Alzheimer's disease	0.00014	0.0022	CbGeAlD
Aripiprazole—KCNH2—central nervous system—Alzheimer's disease	0.00014	0.0022	CbGeAlD
Aripiprazole—HTR2B—brain—Alzheimer's disease	0.000139	0.00218	CbGeAlD
Aripiprazole—DRD2—cerebellum—Alzheimer's disease	0.000139	0.00218	CbGeAlD
Aripiprazole—ADRA2C—central nervous system—Alzheimer's disease	0.000138	0.00217	CbGeAlD
Aripiprazole—KCNH2—cerebellum—Alzheimer's disease	0.000137	0.00215	CbGeAlD
Aripiprazole—ADRA2C—cerebellum—Alzheimer's disease	0.000135	0.00212	CbGeAlD
Aripiprazole—ABCB1—embryo—Alzheimer's disease	0.000133	0.00208	CbGeAlD
Aripiprazole—Trazodone—SLC6A4—Alzheimer's disease	0.000132	0.0394	CrCbGaD
Aripiprazole—Ziprasidone—HTR2A—Alzheimer's disease	0.000131	0.039	CrCbGaD
Aripiprazole—CHRM3—brain—Alzheimer's disease	0.000125	0.00197	CbGeAlD
Aripiprazole—HTR1A—brain—Alzheimer's disease	0.000125	0.00196	CbGeAlD
Aripiprazole—Ziprasidone—CYP2D6—Alzheimer's disease	0.00012	0.0356	CrCbGaD
Aripiprazole—HTR7—brain—Alzheimer's disease	0.000119	0.00187	CbGeAlD
Aripiprazole—ABCB1—forebrain—Alzheimer's disease	0.000118	0.00184	CbGeAlD
Aripiprazole—HRH1—nervous system—Alzheimer's disease	0.000117	0.00183	CbGeAlD
Aripiprazole—ADRA1A—brain—Alzheimer's disease	0.000115	0.0018	CbGeAlD
Aripiprazole—ADRA2A—nervous system—Alzheimer's disease	0.000114	0.0018	CbGeAlD
Aripiprazole—DRD2—brain—Alzheimer's disease	0.000113	0.00177	CbGeAlD
Aripiprazole—HRH1—central nervous system—Alzheimer's disease	0.000112	0.00176	CbGeAlD
Aripiprazole—KCNH2—brain—Alzheimer's disease	0.000111	0.00174	CbGeAlD
Aripiprazole—ADRA2A—central nervous system—Alzheimer's disease	0.00011	0.00173	CbGeAlD
Aripiprazole—Nefazodone—HTR2A—Alzheimer's disease	0.00011	0.0327	CrCbGaD
Aripiprazole—ADRA2C—brain—Alzheimer's disease	0.00011	0.00172	CbGeAlD
Aripiprazole—ABCB1—telencephalon—Alzheimer's disease	0.000108	0.00169	CbGeAlD
Aripiprazole—ADRA2A—cerebellum—Alzheimer's disease	0.000108	0.00169	CbGeAlD
Aripiprazole—Trazodone—HTR2A—Alzheimer's disease	0.000102	0.0303	CrCbGaD
Aripiprazole—Nefazodone—CYP2D6—Alzheimer's disease	0.000101	0.0299	CrCbGaD
Aripiprazole—HTR2A—nervous system—Alzheimer's disease	9.73e-05	0.00153	CbGeAlD
Aripiprazole—HTR2A—central nervous system—Alzheimer's disease	9.37e-05	0.00147	CbGeAlD
Aripiprazole—Trazodone—CYP2D6—Alzheimer's disease	9.3e-05	0.0277	CrCbGaD
Aripiprazole—HTR2A—cerebellum—Alzheimer's disease	9.16e-05	0.00144	CbGeAlD
Aripiprazole—CYP3A4—nervous system—Alzheimer's disease	9.01e-05	0.00141	CbGeAlD
Aripiprazole—HRH1—brain—Alzheimer's disease	8.91e-05	0.0014	CbGeAlD
Aripiprazole—CYP2D6—nervous system—Alzheimer's disease	8.87e-05	0.00139	CbGeAlD
Aripiprazole—ADRA2A—brain—Alzheimer's disease	8.75e-05	0.00137	CbGeAlD
Aripiprazole—CYP3A4—central nervous system—Alzheimer's disease	8.68e-05	0.00136	CbGeAlD
Aripiprazole—CYP2D6—central nervous system—Alzheimer's disease	8.54e-05	0.00134	CbGeAlD
Aripiprazole—CYP2D6—cerebellum—Alzheimer's disease	8.34e-05	0.00131	CbGeAlD
Aripiprazole—Prochlorperazine—CYP2D6—Alzheimer's disease	8.33e-05	0.0248	CrCbGaD
Aripiprazole—HTR2A—brain—Alzheimer's disease	7.44e-05	0.00117	CbGeAlD
Aripiprazole—Connective tissue disorder—Memantine—Alzheimer's disease	7.24e-05	0.0004	CcSEcCtD
Aripiprazole—Rhinitis—Rivastigmine—Alzheimer's disease	7.23e-05	0.000399	CcSEcCtD
Aripiprazole—Skin disorder—Galantamine—Alzheimer's disease	7.23e-05	0.000399	CcSEcCtD
Aripiprazole—Urethral disorder—Memantine—Alzheimer's disease	7.22e-05	0.000399	CcSEcCtD
Aripiprazole—Hepatitis—Rivastigmine—Alzheimer's disease	7.21e-05	0.000398	CcSEcCtD
Aripiprazole—Haemorrhage—Rivastigmine—Alzheimer's disease	7.21e-05	0.000398	CcSEcCtD
Aripiprazole—Hyperhidrosis—Galantamine—Alzheimer's disease	7.19e-05	0.000398	CcSEcCtD
Aripiprazole—Hypoaesthesia—Rivastigmine—Alzheimer's disease	7.17e-05	0.000396	CcSEcCtD
Aripiprazole—Hallucination—Rivastigmine—Alzheimer's disease	7.17e-05	0.000396	CcSEcCtD
Aripiprazole—Alopecia—Donepezil—Alzheimer's disease	7.17e-05	0.000396	CcSEcCtD
Aripiprazole—Pharyngitis—Rivastigmine—Alzheimer's disease	7.15e-05	0.000395	CcSEcCtD
Aripiprazole—Urinary tract disorder—Rivastigmine—Alzheimer's disease	7.12e-05	0.000394	CcSEcCtD
Aripiprazole—Mental disorder—Donepezil—Alzheimer's disease	7.11e-05	0.000393	CcSEcCtD
Aripiprazole—Oedema peripheral—Rivastigmine—Alzheimer's disease	7.1e-05	0.000393	CcSEcCtD
Aripiprazole—Visual impairment—Memantine—Alzheimer's disease	7.1e-05	0.000393	CcSEcCtD
Aripiprazole—Anorexia—Galantamine—Alzheimer's disease	7.09e-05	0.000392	CcSEcCtD
Aripiprazole—Connective tissue disorder—Rivastigmine—Alzheimer's disease	7.08e-05	0.000392	CcSEcCtD
Aripiprazole—Urethral disorder—Rivastigmine—Alzheimer's disease	7.07e-05	0.000391	CcSEcCtD
Aripiprazole—Erythema—Donepezil—Alzheimer's disease	7.07e-05	0.000391	CcSEcCtD
Aripiprazole—Malnutrition—Donepezil—Alzheimer's disease	7.07e-05	0.000391	CcSEcCtD
Aripiprazole—Flatulence—Donepezil—Alzheimer's disease	6.96e-05	0.000385	CcSEcCtD
Aripiprazole—Hypotension—Galantamine—Alzheimer's disease	6.95e-05	0.000384	CcSEcCtD
Aripiprazole—Visual impairment—Rivastigmine—Alzheimer's disease	6.95e-05	0.000384	CcSEcCtD
Aripiprazole—Tension—Donepezil—Alzheimer's disease	6.93e-05	0.000383	CcSEcCtD
Aripiprazole—Dysgeusia—Donepezil—Alzheimer's disease	6.92e-05	0.000382	CcSEcCtD
Aripiprazole—Eye disorder—Memantine—Alzheimer's disease	6.89e-05	0.000381	CcSEcCtD
Aripiprazole—Tinnitus—Memantine—Alzheimer's disease	6.87e-05	0.00038	CcSEcCtD
Aripiprazole—Nervousness—Donepezil—Alzheimer's disease	6.86e-05	0.000379	CcSEcCtD
Aripiprazole—Cardiac disorder—Memantine—Alzheimer's disease	6.84e-05	0.000378	CcSEcCtD
Aripiprazole—Flushing—Memantine—Alzheimer's disease	6.84e-05	0.000378	CcSEcCtD
Aripiprazole—Back pain—Donepezil—Alzheimer's disease	6.83e-05	0.000378	CcSEcCtD
Aripiprazole—Muscle spasms—Donepezil—Alzheimer's disease	6.79e-05	0.000375	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	6.78e-05	0.000375	CcSEcCtD
Aripiprazole—CYP2D6—brain—Alzheimer's disease	6.78e-05	0.00106	CbGeAlD
Aripiprazole—Eye disorder—Rivastigmine—Alzheimer's disease	6.74e-05	0.000372	CcSEcCtD
Aripiprazole—Insomnia—Galantamine—Alzheimer's disease	6.73e-05	0.000372	CcSEcCtD
Aripiprazole—Tinnitus—Rivastigmine—Alzheimer's disease	6.72e-05	0.000372	CcSEcCtD
Aripiprazole—Flushing—Rivastigmine—Alzheimer's disease	6.69e-05	0.00037	CcSEcCtD
Aripiprazole—Cardiac disorder—Rivastigmine—Alzheimer's disease	6.69e-05	0.00037	CcSEcCtD
Aripiprazole—Angiopathy—Memantine—Alzheimer's disease	6.69e-05	0.00037	CcSEcCtD
Aripiprazole—Paraesthesia—Galantamine—Alzheimer's disease	6.68e-05	0.000369	CcSEcCtD
Aripiprazole—Vision blurred—Donepezil—Alzheimer's disease	6.66e-05	0.000368	CcSEcCtD
Aripiprazole—Immune system disorder—Memantine—Alzheimer's disease	6.66e-05	0.000368	CcSEcCtD
Aripiprazole—Mediastinal disorder—Memantine—Alzheimer's disease	6.64e-05	0.000367	CcSEcCtD
Aripiprazole—Tremor—Donepezil—Alzheimer's disease	6.62e-05	0.000366	CcSEcCtD
Aripiprazole—Somnolence—Galantamine—Alzheimer's disease	6.61e-05	0.000366	CcSEcCtD
Aripiprazole—Chills—Memantine—Alzheimer's disease	6.61e-05	0.000365	CcSEcCtD
Aripiprazole—Ill-defined disorder—Donepezil—Alzheimer's disease	6.56e-05	0.000362	CcSEcCtD
Aripiprazole—Dyspepsia—Galantamine—Alzheimer's disease	6.55e-05	0.000362	CcSEcCtD
Aripiprazole—Angiopathy—Rivastigmine—Alzheimer's disease	6.54e-05	0.000362	CcSEcCtD
Aripiprazole—Anaemia—Donepezil—Alzheimer's disease	6.53e-05	0.000361	CcSEcCtD
Aripiprazole—Perphenazine—HTR2A—Alzheimer's disease	6.51e-05	0.0194	CrCbGaD
Aripiprazole—Alopecia—Memantine—Alzheimer's disease	6.51e-05	0.00036	CcSEcCtD
Aripiprazole—Mediastinal disorder—Rivastigmine—Alzheimer's disease	6.5e-05	0.000359	CcSEcCtD
Aripiprazole—Agitation—Donepezil—Alzheimer's disease	6.49e-05	0.000359	CcSEcCtD
Aripiprazole—Chills—Rivastigmine—Alzheimer's disease	6.47e-05	0.000358	CcSEcCtD
Aripiprazole—Decreased appetite—Galantamine—Alzheimer's disease	6.47e-05	0.000357	CcSEcCtD
Aripiprazole—Mental disorder—Memantine—Alzheimer's disease	6.46e-05	0.000357	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Galantamine—Alzheimer's disease	6.42e-05	0.000355	CcSEcCtD
Aripiprazole—Malnutrition—Memantine—Alzheimer's disease	6.41e-05	0.000355	CcSEcCtD
Aripiprazole—Fatigue—Galantamine—Alzheimer's disease	6.41e-05	0.000355	CcSEcCtD
Aripiprazole—ABCB1—nervous system—Alzheimer's disease	6.38e-05	0.001	CbGeAlD
Aripiprazole—Malaise—Donepezil—Alzheimer's disease	6.37e-05	0.000352	CcSEcCtD
Aripiprazole—Alopecia—Rivastigmine—Alzheimer's disease	6.37e-05	0.000352	CcSEcCtD
Aripiprazole—Constipation—Galantamine—Alzheimer's disease	6.36e-05	0.000352	CcSEcCtD
Aripiprazole—Vertigo—Donepezil—Alzheimer's disease	6.35e-05	0.000351	CcSEcCtD
Aripiprazole—Syncope—Donepezil—Alzheimer's disease	6.34e-05	0.00035	CcSEcCtD
Aripiprazole—Flatulence—Memantine—Alzheimer's disease	6.32e-05	0.000349	CcSEcCtD
Aripiprazole—Mental disorder—Rivastigmine—Alzheimer's disease	6.32e-05	0.000349	CcSEcCtD
Aripiprazole—Tension—Memantine—Alzheimer's disease	6.29e-05	0.000348	CcSEcCtD
Aripiprazole—Dysgeusia—Memantine—Alzheimer's disease	6.28e-05	0.000347	CcSEcCtD
Aripiprazole—Erythema—Rivastigmine—Alzheimer's disease	6.28e-05	0.000347	CcSEcCtD
Aripiprazole—Malnutrition—Rivastigmine—Alzheimer's disease	6.28e-05	0.000347	CcSEcCtD
Aripiprazole—Nervousness—Memantine—Alzheimer's disease	6.23e-05	0.000344	CcSEcCtD
Aripiprazole—Loss of consciousness—Donepezil—Alzheimer's disease	6.21e-05	0.000343	CcSEcCtD
Aripiprazole—Back pain—Memantine—Alzheimer's disease	6.21e-05	0.000343	CcSEcCtD
Aripiprazole—Flatulence—Rivastigmine—Alzheimer's disease	6.18e-05	0.000342	CcSEcCtD
Aripiprazole—Cough—Donepezil—Alzheimer's disease	6.17e-05	0.000341	CcSEcCtD
Aripiprazole—Tension—Rivastigmine—Alzheimer's disease	6.16e-05	0.00034	CcSEcCtD
Aripiprazole—Dysgeusia—Rivastigmine—Alzheimer's disease	6.15e-05	0.00034	CcSEcCtD
Aripiprazole—ABCB1—central nervous system—Alzheimer's disease	6.14e-05	0.000963	CbGeAlD
Aripiprazole—Feeling abnormal—Galantamine—Alzheimer's disease	6.13e-05	0.000339	CcSEcCtD
Aripiprazole—Convulsion—Donepezil—Alzheimer's disease	6.12e-05	0.000338	CcSEcCtD
Aripiprazole—Hypertension—Donepezil—Alzheimer's disease	6.1e-05	0.000337	CcSEcCtD
Aripiprazole—Nervousness—Rivastigmine—Alzheimer's disease	6.1e-05	0.000337	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Galantamine—Alzheimer's disease	6.08e-05	0.000336	CcSEcCtD
Aripiprazole—Back pain—Rivastigmine—Alzheimer's disease	6.07e-05	0.000336	CcSEcCtD
Aripiprazole—Vision blurred—Memantine—Alzheimer's disease	6.05e-05	0.000334	CcSEcCtD
Aripiprazole—Muscle spasms—Rivastigmine—Alzheimer's disease	6.03e-05	0.000333	CcSEcCtD
Aripiprazole—Myalgia—Donepezil—Alzheimer's disease	6.01e-05	0.000332	CcSEcCtD
Aripiprazole—Chest pain—Donepezil—Alzheimer's disease	6.01e-05	0.000332	CcSEcCtD
Aripiprazole—Arthralgia—Donepezil—Alzheimer's disease	6.01e-05	0.000332	CcSEcCtD
Aripiprazole—Tremor—Memantine—Alzheimer's disease	6.01e-05	0.000332	CcSEcCtD
Aripiprazole—ABCB1—cerebellum—Alzheimer's disease	6e-05	0.000941	CbGeAlD
Aripiprazole—Anxiety—Donepezil—Alzheimer's disease	5.99e-05	0.000331	CcSEcCtD
Aripiprazole—Perphenazine—CYP2D6—Alzheimer's disease	5.96e-05	0.0177	CrCbGaD
Aripiprazole—Ill-defined disorder—Memantine—Alzheimer's disease	5.95e-05	0.000329	CcSEcCtD
Aripiprazole—Discomfort—Donepezil—Alzheimer's disease	5.94e-05	0.000328	CcSEcCtD
Aripiprazole—Anaemia—Memantine—Alzheimer's disease	5.93e-05	0.000328	CcSEcCtD
Aripiprazole—Vision blurred—Rivastigmine—Alzheimer's disease	5.91e-05	0.000327	CcSEcCtD
Aripiprazole—Agitation—Memantine—Alzheimer's disease	5.9e-05	0.000326	CcSEcCtD
Aripiprazole—Dry mouth—Donepezil—Alzheimer's disease	5.88e-05	0.000325	CcSEcCtD
Aripiprazole—Body temperature increased—Galantamine—Alzheimer's disease	5.88e-05	0.000325	CcSEcCtD
Aripiprazole—Abdominal pain—Galantamine—Alzheimer's disease	5.88e-05	0.000325	CcSEcCtD
Aripiprazole—Tremor—Rivastigmine—Alzheimer's disease	5.88e-05	0.000325	CcSEcCtD
Aripiprazole—Ill-defined disorder—Rivastigmine—Alzheimer's disease	5.82e-05	0.000322	CcSEcCtD
Aripiprazole—Confusional state—Donepezil—Alzheimer's disease	5.81e-05	0.000321	CcSEcCtD
Aripiprazole—Anaemia—Rivastigmine—Alzheimer's disease	5.8e-05	0.000321	CcSEcCtD
Aripiprazole—Malaise—Memantine—Alzheimer's disease	5.78e-05	0.00032	CcSEcCtD
Aripiprazole—Agitation—Rivastigmine—Alzheimer's disease	5.77e-05	0.000319	CcSEcCtD
Aripiprazole—Oedema—Donepezil—Alzheimer's disease	5.77e-05	0.000319	CcSEcCtD
Aripiprazole—Vertigo—Memantine—Alzheimer's disease	5.76e-05	0.000319	CcSEcCtD
Aripiprazole—Syncope—Memantine—Alzheimer's disease	5.75e-05	0.000318	CcSEcCtD
Aripiprazole—Leukopenia—Memantine—Alzheimer's disease	5.74e-05	0.000317	CcSEcCtD
Aripiprazole—Infection—Donepezil—Alzheimer's disease	5.73e-05	0.000317	CcSEcCtD
Aripiprazole—Shock—Donepezil—Alzheimer's disease	5.67e-05	0.000314	CcSEcCtD
Aripiprazole—Palpitations—Memantine—Alzheimer's disease	5.67e-05	0.000313	CcSEcCtD
Aripiprazole—Malaise—Rivastigmine—Alzheimer's disease	5.66e-05	0.000313	CcSEcCtD
Aripiprazole—Nervous system disorder—Donepezil—Alzheimer's disease	5.65e-05	0.000313	CcSEcCtD
Aripiprazole—Thrombocytopenia—Donepezil—Alzheimer's disease	5.65e-05	0.000312	CcSEcCtD
Aripiprazole—Vertigo—Rivastigmine—Alzheimer's disease	5.64e-05	0.000312	CcSEcCtD
Aripiprazole—Loss of consciousness—Memantine—Alzheimer's disease	5.64e-05	0.000312	CcSEcCtD
Aripiprazole—Syncope—Rivastigmine—Alzheimer's disease	5.63e-05	0.000311	CcSEcCtD
Aripiprazole—Cough—Memantine—Alzheimer's disease	5.6e-05	0.000309	CcSEcCtD
Aripiprazole—Hyperhidrosis—Donepezil—Alzheimer's disease	5.57e-05	0.000308	CcSEcCtD
Aripiprazole—Convulsion—Memantine—Alzheimer's disease	5.56e-05	0.000307	CcSEcCtD
Aripiprazole—Palpitations—Rivastigmine—Alzheimer's disease	5.55e-05	0.000307	CcSEcCtD
Aripiprazole—Hypertension—Memantine—Alzheimer's disease	5.54e-05	0.000306	CcSEcCtD
Aripiprazole—Loss of consciousness—Rivastigmine—Alzheimer's disease	5.52e-05	0.000305	CcSEcCtD
Aripiprazole—Anorexia—Donepezil—Alzheimer's disease	5.5e-05	0.000304	CcSEcCtD
Aripiprazole—Hypersensitivity—Galantamine—Alzheimer's disease	5.48e-05	0.000303	CcSEcCtD
Aripiprazole—Cough—Rivastigmine—Alzheimer's disease	5.48e-05	0.000303	CcSEcCtD
Aripiprazole—Arthralgia—Memantine—Alzheimer's disease	5.46e-05	0.000302	CcSEcCtD
Aripiprazole—Chest pain—Memantine—Alzheimer's disease	5.46e-05	0.000302	CcSEcCtD
Aripiprazole—Myalgia—Memantine—Alzheimer's disease	5.46e-05	0.000302	CcSEcCtD
Aripiprazole—Anxiety—Memantine—Alzheimer's disease	5.44e-05	0.000301	CcSEcCtD
Aripiprazole—Convulsion—Rivastigmine—Alzheimer's disease	5.44e-05	0.000301	CcSEcCtD
Aripiprazole—Hypertension—Rivastigmine—Alzheimer's disease	5.42e-05	0.000299	CcSEcCtD
Aripiprazole—Discomfort—Memantine—Alzheimer's disease	5.4e-05	0.000298	CcSEcCtD
Aripiprazole—Hypotension—Donepezil—Alzheimer's disease	5.39e-05	0.000298	CcSEcCtD
Aripiprazole—Chest pain—Rivastigmine—Alzheimer's disease	5.34e-05	0.000295	CcSEcCtD
Aripiprazole—Myalgia—Rivastigmine—Alzheimer's disease	5.34e-05	0.000295	CcSEcCtD
Aripiprazole—Arthralgia—Rivastigmine—Alzheimer's disease	5.34e-05	0.000295	CcSEcCtD
Aripiprazole—Dry mouth—Memantine—Alzheimer's disease	5.34e-05	0.000295	CcSEcCtD
Aripiprazole—Asthenia—Galantamine—Alzheimer's disease	5.34e-05	0.000295	CcSEcCtD
Aripiprazole—Anxiety—Rivastigmine—Alzheimer's disease	5.32e-05	0.000294	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	5.31e-05	0.000293	CcSEcCtD
Aripiprazole—Confusional state—Memantine—Alzheimer's disease	5.28e-05	0.000292	CcSEcCtD
Aripiprazole—Discomfort—Rivastigmine—Alzheimer's disease	5.28e-05	0.000292	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	5.25e-05	0.00029	CcSEcCtD
Aripiprazole—Oedema—Memantine—Alzheimer's disease	5.24e-05	0.000289	CcSEcCtD
Aripiprazole—Dry mouth—Rivastigmine—Alzheimer's disease	5.23e-05	0.000289	CcSEcCtD
Aripiprazole—Insomnia—Donepezil—Alzheimer's disease	5.22e-05	0.000288	CcSEcCtD
Aripiprazole—Infection—Memantine—Alzheimer's disease	5.2e-05	0.000287	CcSEcCtD
Aripiprazole—Paraesthesia—Donepezil—Alzheimer's disease	5.18e-05	0.000286	CcSEcCtD
Aripiprazole—Confusional state—Rivastigmine—Alzheimer's disease	5.16e-05	0.000285	CcSEcCtD
Aripiprazole—Shock—Memantine—Alzheimer's disease	5.15e-05	0.000285	CcSEcCtD
Aripiprazole—Dyspnoea—Donepezil—Alzheimer's disease	5.14e-05	0.000284	CcSEcCtD
Aripiprazole—Nervous system disorder—Memantine—Alzheimer's disease	5.13e-05	0.000284	CcSEcCtD
Aripiprazole—Somnolence—Donepezil—Alzheimer's disease	5.13e-05	0.000283	CcSEcCtD
Aripiprazole—Thrombocytopenia—Memantine—Alzheimer's disease	5.13e-05	0.000283	CcSEcCtD
Aripiprazole—Oedema—Rivastigmine—Alzheimer's disease	5.12e-05	0.000283	CcSEcCtD
Aripiprazole—Tachycardia—Memantine—Alzheimer's disease	5.11e-05	0.000282	CcSEcCtD
Aripiprazole—Diarrhoea—Galantamine—Alzheimer's disease	5.09e-05	0.000281	CcSEcCtD
Aripiprazole—Infection—Rivastigmine—Alzheimer's disease	5.09e-05	0.000281	CcSEcCtD
Aripiprazole—Skin disorder—Memantine—Alzheimer's disease	5.09e-05	0.000281	CcSEcCtD
Aripiprazole—Dyspepsia—Donepezil—Alzheimer's disease	5.08e-05	0.000281	CcSEcCtD
Aripiprazole—Hyperhidrosis—Memantine—Alzheimer's disease	5.06e-05	0.00028	CcSEcCtD
Aripiprazole—Shock—Rivastigmine—Alzheimer's disease	5.04e-05	0.000279	CcSEcCtD
Aripiprazole—Nervous system disorder—Rivastigmine—Alzheimer's disease	5.02e-05	0.000278	CcSEcCtD
Aripiprazole—Thrombocytopenia—Rivastigmine—Alzheimer's disease	5.01e-05	0.000277	CcSEcCtD
Aripiprazole—Decreased appetite—Donepezil—Alzheimer's disease	5.01e-05	0.000277	CcSEcCtD
Aripiprazole—Tachycardia—Rivastigmine—Alzheimer's disease	5e-05	0.000276	CcSEcCtD
Aripiprazole—Anorexia—Memantine—Alzheimer's disease	4.99e-05	0.000276	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Donepezil—Alzheimer's disease	4.98e-05	0.000275	CcSEcCtD
Aripiprazole—Skin disorder—Rivastigmine—Alzheimer's disease	4.97e-05	0.000275	CcSEcCtD
Aripiprazole—Fatigue—Donepezil—Alzheimer's disease	4.97e-05	0.000275	CcSEcCtD
Aripiprazole—Hyperhidrosis—Rivastigmine—Alzheimer's disease	4.95e-05	0.000274	CcSEcCtD
Aripiprazole—Pain—Donepezil—Alzheimer's disease	4.93e-05	0.000273	CcSEcCtD
Aripiprazole—Constipation—Donepezil—Alzheimer's disease	4.93e-05	0.000273	CcSEcCtD
Aripiprazole—Dizziness—Galantamine—Alzheimer's disease	4.92e-05	0.000272	CcSEcCtD
Aripiprazole—Hypotension—Memantine—Alzheimer's disease	4.89e-05	0.00027	CcSEcCtD
Aripiprazole—Anorexia—Rivastigmine—Alzheimer's disease	4.88e-05	0.00027	CcSEcCtD
Aripiprazole—ABCB1—brain—Alzheimer's disease	4.88e-05	0.000765	CbGeAlD
Aripiprazole—Hypotension—Rivastigmine—Alzheimer's disease	4.79e-05	0.000265	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Memantine—Alzheimer's disease	4.77e-05	0.000264	CcSEcCtD
Aripiprazole—Feeling abnormal—Donepezil—Alzheimer's disease	4.75e-05	0.000263	CcSEcCtD
Aripiprazole—Insomnia—Memantine—Alzheimer's disease	4.74e-05	0.000262	CcSEcCtD
Aripiprazole—Vomiting—Galantamine—Alzheimer's disease	4.73e-05	0.000261	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Donepezil—Alzheimer's disease	4.72e-05	0.000261	CcSEcCtD
Aripiprazole—Paraesthesia—Memantine—Alzheimer's disease	4.7e-05	0.00026	CcSEcCtD
Aripiprazole—Rash—Galantamine—Alzheimer's disease	4.69e-05	0.000259	CcSEcCtD
Aripiprazole—Dermatitis—Galantamine—Alzheimer's disease	4.69e-05	0.000259	CcSEcCtD
Aripiprazole—Dyspnoea—Memantine—Alzheimer's disease	4.67e-05	0.000258	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	4.67e-05	0.000258	CcSEcCtD
Aripiprazole—Headache—Galantamine—Alzheimer's disease	4.66e-05	0.000258	CcSEcCtD
Aripiprazole—Somnolence—Memantine—Alzheimer's disease	4.65e-05	0.000257	CcSEcCtD
Aripiprazole—Insomnia—Rivastigmine—Alzheimer's disease	4.63e-05	0.000256	CcSEcCtD
Aripiprazole—Dyspepsia—Memantine—Alzheimer's disease	4.61e-05	0.000255	CcSEcCtD
Aripiprazole—Paraesthesia—Rivastigmine—Alzheimer's disease	4.6e-05	0.000254	CcSEcCtD
Aripiprazole—Urticaria—Donepezil—Alzheimer's disease	4.58e-05	0.000253	CcSEcCtD
Aripiprazole—Dyspnoea—Rivastigmine—Alzheimer's disease	4.57e-05	0.000252	CcSEcCtD
Aripiprazole—Abdominal pain—Donepezil—Alzheimer's disease	4.56e-05	0.000252	CcSEcCtD
Aripiprazole—Body temperature increased—Donepezil—Alzheimer's disease	4.56e-05	0.000252	CcSEcCtD
Aripiprazole—Somnolence—Rivastigmine—Alzheimer's disease	4.55e-05	0.000252	CcSEcCtD
Aripiprazole—Decreased appetite—Memantine—Alzheimer's disease	4.55e-05	0.000252	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Memantine—Alzheimer's disease	4.52e-05	0.00025	CcSEcCtD
Aripiprazole—Fatigue—Memantine—Alzheimer's disease	4.51e-05	0.000249	CcSEcCtD
Aripiprazole—Dyspepsia—Rivastigmine—Alzheimer's disease	4.51e-05	0.000249	CcSEcCtD
Aripiprazole—Pain—Memantine—Alzheimer's disease	4.48e-05	0.000247	CcSEcCtD
Aripiprazole—Constipation—Memantine—Alzheimer's disease	4.48e-05	0.000247	CcSEcCtD
Aripiprazole—Decreased appetite—Rivastigmine—Alzheimer's disease	4.45e-05	0.000246	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	4.42e-05	0.000244	CcSEcCtD
Aripiprazole—Nausea—Galantamine—Alzheimer's disease	4.42e-05	0.000244	CcSEcCtD
Aripiprazole—Fatigue—Rivastigmine—Alzheimer's disease	4.42e-05	0.000244	CcSEcCtD
Aripiprazole—Constipation—Rivastigmine—Alzheimer's disease	4.38e-05	0.000242	CcSEcCtD
Aripiprazole—Pain—Rivastigmine—Alzheimer's disease	4.38e-05	0.000242	CcSEcCtD
Aripiprazole—Feeling abnormal—Memantine—Alzheimer's disease	4.31e-05	0.000238	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Memantine—Alzheimer's disease	4.28e-05	0.000237	CcSEcCtD
Aripiprazole—Hypersensitivity—Donepezil—Alzheimer's disease	4.25e-05	0.000235	CcSEcCtD
Aripiprazole—Feeling abnormal—Rivastigmine—Alzheimer's disease	4.22e-05	0.000233	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	4.19e-05	0.000231	CcSEcCtD
Aripiprazole—Urticaria—Memantine—Alzheimer's disease	4.16e-05	0.00023	CcSEcCtD
Aripiprazole—Body temperature increased—Memantine—Alzheimer's disease	4.14e-05	0.000229	CcSEcCtD
Aripiprazole—Abdominal pain—Memantine—Alzheimer's disease	4.14e-05	0.000229	CcSEcCtD
Aripiprazole—Asthenia—Donepezil—Alzheimer's disease	4.14e-05	0.000229	CcSEcCtD
Aripiprazole—Pruritus—Donepezil—Alzheimer's disease	4.08e-05	0.000225	CcSEcCtD
Aripiprazole—Urticaria—Rivastigmine—Alzheimer's disease	4.07e-05	0.000225	CcSEcCtD
Aripiprazole—Abdominal pain—Rivastigmine—Alzheimer's disease	4.05e-05	0.000224	CcSEcCtD
Aripiprazole—Body temperature increased—Rivastigmine—Alzheimer's disease	4.05e-05	0.000224	CcSEcCtD
Aripiprazole—Diarrhoea—Donepezil—Alzheimer's disease	3.95e-05	0.000218	CcSEcCtD
Aripiprazole—Hypersensitivity—Memantine—Alzheimer's disease	3.86e-05	0.000213	CcSEcCtD
Aripiprazole—Dizziness—Donepezil—Alzheimer's disease	3.81e-05	0.000211	CcSEcCtD
Aripiprazole—Hypersensitivity—Rivastigmine—Alzheimer's disease	3.77e-05	0.000209	CcSEcCtD
Aripiprazole—Asthenia—Memantine—Alzheimer's disease	3.76e-05	0.000208	CcSEcCtD
Aripiprazole—Pruritus—Memantine—Alzheimer's disease	3.7e-05	0.000205	CcSEcCtD
Aripiprazole—Asthenia—Rivastigmine—Alzheimer's disease	3.67e-05	0.000203	CcSEcCtD
Aripiprazole—Vomiting—Donepezil—Alzheimer's disease	3.67e-05	0.000203	CcSEcCtD
Aripiprazole—Rash—Donepezil—Alzheimer's disease	3.64e-05	0.000201	CcSEcCtD
Aripiprazole—Dermatitis—Donepezil—Alzheimer's disease	3.63e-05	0.000201	CcSEcCtD
Aripiprazole—Pruritus—Rivastigmine—Alzheimer's disease	3.62e-05	0.0002	CcSEcCtD
Aripiprazole—Headache—Donepezil—Alzheimer's disease	3.61e-05	0.0002	CcSEcCtD
Aripiprazole—Diarrhoea—Memantine—Alzheimer's disease	3.58e-05	0.000198	CcSEcCtD
Aripiprazole—Diarrhoea—Rivastigmine—Alzheimer's disease	3.5e-05	0.000194	CcSEcCtD
Aripiprazole—Dizziness—Memantine—Alzheimer's disease	3.46e-05	0.000191	CcSEcCtD
Aripiprazole—Nausea—Donepezil—Alzheimer's disease	3.42e-05	0.000189	CcSEcCtD
Aripiprazole—Dizziness—Rivastigmine—Alzheimer's disease	3.39e-05	0.000187	CcSEcCtD
Aripiprazole—Vomiting—Memantine—Alzheimer's disease	3.33e-05	0.000184	CcSEcCtD
Aripiprazole—Rash—Memantine—Alzheimer's disease	3.3e-05	0.000182	CcSEcCtD
Aripiprazole—Dermatitis—Memantine—Alzheimer's disease	3.3e-05	0.000182	CcSEcCtD
Aripiprazole—Headache—Memantine—Alzheimer's disease	3.28e-05	0.000181	CcSEcCtD
Aripiprazole—Vomiting—Rivastigmine—Alzheimer's disease	3.26e-05	0.00018	CcSEcCtD
Aripiprazole—Rash—Rivastigmine—Alzheimer's disease	3.23e-05	0.000178	CcSEcCtD
Aripiprazole—Dermatitis—Rivastigmine—Alzheimer's disease	3.23e-05	0.000178	CcSEcCtD
Aripiprazole—Headache—Rivastigmine—Alzheimer's disease	3.21e-05	0.000177	CcSEcCtD
Aripiprazole—Nausea—Memantine—Alzheimer's disease	3.11e-05	0.000172	CcSEcCtD
Aripiprazole—Nausea—Rivastigmine—Alzheimer's disease	3.04e-05	0.000168	CcSEcCtD
Aripiprazole—CHRM3—Metabolism—PTGS2—Alzheimer's disease	1.65e-06	2.11e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	1.65e-06	2.1e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	1.64e-06	2.1e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.64e-06	2.09e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—VEGFA—Alzheimer's disease	1.64e-06	2.09e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—VEGFA—Alzheimer's disease	1.62e-06	2.06e-05	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—AKT1—Alzheimer's disease	1.6e-06	2.04e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	1.6e-06	2.04e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—MAPK8—Alzheimer's disease	1.6e-06	2.04e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—AKT1—Alzheimer's disease	1.59e-06	2.03e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	1.59e-06	2.03e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	1.58e-06	2.01e-05	CbGpPWpGaD
Aripiprazole—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.58e-06	2.01e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—MAPK8—Alzheimer's disease	1.58e-06	2.01e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—TGFB1—Alzheimer's disease	1.57e-06	2.01e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—AKT1—Alzheimer's disease	1.57e-06	2.01e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—TGFB1—Alzheimer's disease	1.57e-06	2.01e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.56e-06	2e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	1.56e-06	2e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.56e-06	2e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	1.56e-06	1.99e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	1.56e-06	1.99e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	1.55e-06	1.98e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	1.55e-06	1.98e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	1.55e-06	1.98e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	1.55e-06	1.98e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	1.55e-06	1.97e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	1.55e-06	1.97e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	1.54e-06	1.96e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—IL6—Alzheimer's disease	1.54e-06	1.96e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.53e-06	1.96e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.53e-06	1.95e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—APOE—Alzheimer's disease	1.53e-06	1.95e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	1.53e-06	1.95e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	1.52e-06	1.94e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	1.52e-06	1.94e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—NOS3—Alzheimer's disease	1.52e-06	1.94e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	1.51e-06	1.93e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.51e-06	1.93e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	1.51e-06	1.93e-05	CbGpPWpGaD
Aripiprazole—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.51e-06	1.93e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	1.51e-06	1.93e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—TGFB1—Alzheimer's disease	1.5e-06	1.92e-05	CbGpPWpGaD
Aripiprazole—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.5e-06	1.92e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.49e-06	1.91e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	1.49e-06	1.91e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	1.49e-06	1.9e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	1.49e-06	1.9e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.48e-06	1.9e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TGFB1—Alzheimer's disease	1.48e-06	1.89e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	1.48e-06	1.89e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.48e-06	1.88e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—VEGFA—Alzheimer's disease	1.47e-06	1.88e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—GPCR downstream signaling—AKT1—Alzheimer's disease	1.46e-06	1.86e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—VEGFA—Alzheimer's disease	1.46e-06	1.86e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CASP3—Alzheimer's disease	1.45e-06	1.85e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.44e-06	1.84e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.44e-06	1.84e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—IL6—Alzheimer's disease	1.44e-06	1.83e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.44e-06	1.83e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	1.44e-06	1.83e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.44e-06	1.83e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	1.43e-06	1.83e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.43e-06	1.83e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.43e-06	1.82e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	1.42e-06	1.82e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	1.42e-06	1.82e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	1.42e-06	1.81e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	1.42e-06	1.81e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—AKT1—Alzheimer's disease	1.42e-06	1.81e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	1.41e-06	1.81e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	1.39e-06	1.77e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	1.38e-06	1.77e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.37e-06	1.75e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.37e-06	1.75e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.37e-06	1.74e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.36e-06	1.74e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TGFB1—Alzheimer's disease	1.35e-06	1.73e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TGFB1—Alzheimer's disease	1.34e-06	1.71e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.33e-06	1.7e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—MAPK8—Alzheimer's disease	1.33e-06	1.7e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	1.33e-06	1.69e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—AKT1—Alzheimer's disease	1.33e-06	1.69e-05	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.32e-06	1.69e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	1.31e-06	1.68e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.31e-06	1.68e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	1.31e-06	1.67e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—INS—Alzheimer's disease	1.3e-06	1.67e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	1.3e-06	1.67e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.3e-06	1.66e-05	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.3e-06	1.66e-05	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.3e-06	1.66e-05	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	1.3e-06	1.65e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—TP53—Alzheimer's disease	1.29e-06	1.65e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—TP53—Alzheimer's disease	1.29e-06	1.65e-05	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	1.29e-06	1.65e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	1.29e-06	1.65e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	1.29e-06	1.64e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	1.28e-06	1.64e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	1.28e-06	1.64e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	1.28e-06	1.64e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	1.28e-06	1.63e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	1.28e-06	1.63e-05	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.28e-06	1.63e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.28e-06	1.63e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	1.28e-06	1.63e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	1.27e-06	1.62e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.27e-06	1.62e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	1.27e-06	1.62e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	1.26e-06	1.61e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.26e-06	1.61e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	1.26e-06	1.61e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—TP53—Alzheimer's disease	1.26e-06	1.61e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	1.26e-06	1.6e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.25e-06	1.6e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—TP53—Alzheimer's disease	1.24e-06	1.58e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.23e-06	1.57e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—INS—Alzheimer's disease	1.23e-06	1.57e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.23e-06	1.57e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—VEGFA—Alzheimer's disease	1.23e-06	1.57e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TP53—Alzheimer's disease	1.22e-06	1.56e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	1.22e-06	1.55e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.21e-06	1.54e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.21e-06	1.54e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.21e-06	1.54e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.2e-06	1.54e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.19e-06	1.52e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.19e-06	1.51e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IL6—Alzheimer's disease	1.19e-06	1.51e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	1.18e-06	1.51e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IL6—Alzheimer's disease	1.18e-06	1.51e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.18e-06	1.51e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	1.18e-06	1.51e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	1.18e-06	1.51e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	1.18e-06	1.51e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	1.18e-06	1.5e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	1.18e-06	1.5e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	1.18e-06	1.5e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	1.17e-06	1.5e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	1.17e-06	1.5e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	1.17e-06	1.49e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	1.17e-06	1.49e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	1.17e-06	1.49e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.16e-06	1.49e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	1.16e-06	1.48e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.16e-06	1.48e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.16e-06	1.48e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.16e-06	1.48e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IL6—Alzheimer's disease	1.15e-06	1.47e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.14e-06	1.46e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IL6—Alzheimer's disease	1.13e-06	1.45e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.13e-06	1.44e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.12e-06	1.43e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL6—Alzheimer's disease	1.12e-06	1.43e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TP53—Alzheimer's disease	1.11e-06	1.42e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.11e-06	1.42e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.11e-06	1.42e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TP53—Alzheimer's disease	1.1e-06	1.4e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.1e-06	1.4e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.09e-06	1.4e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	1.09e-06	1.4e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—AKT1—Alzheimer's disease	1.09e-06	1.39e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	1.09e-06	1.39e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	1.09e-06	1.39e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	1.08e-06	1.39e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	1.08e-06	1.38e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.08e-06	1.38e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.08e-06	1.38e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.08e-06	1.37e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	1.08e-06	1.37e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.07e-06	1.37e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	1.07e-06	1.37e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—AKT1—Alzheimer's disease	1.06e-06	1.36e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.05e-06	1.34e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—AKT1—Alzheimer's disease	1.05e-06	1.33e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—AKT1—Alzheimer's disease	1.03e-06	1.32e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.02e-06	1.3e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL6—Alzheimer's disease	1.02e-06	1.3e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.01e-06	1.29e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL6—Alzheimer's disease	1.01e-06	1.29e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.01e-06	1.28e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1e-06	1.28e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	1e-06	1.28e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	1e-06	1.28e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	9.98e-07	1.27e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	9.97e-07	1.27e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	9.97e-07	1.27e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	9.93e-07	1.27e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	9.88e-07	1.26e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	9.87e-07	1.26e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	9.86e-07	1.26e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	9.85e-07	1.26e-05	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—AKT1—Alzheimer's disease	9.64e-07	1.23e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	9.58e-07	1.22e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	9.53e-07	1.22e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CALM1—Alzheimer's disease	9.44e-07	1.21e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—AKT1—Alzheimer's disease	9.41e-07	1.2e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOE—Alzheimer's disease	9.41e-07	1.2e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—AKT1—Alzheimer's disease	9.36e-07	1.2e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CAV1—Alzheimer's disease	9.32e-07	1.19e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—AKT1—Alzheimer's disease	9.29e-07	1.19e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TP53—Alzheimer's disease	9.27e-07	1.18e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	9.17e-07	1.17e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	9.15e-07	1.17e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	9.13e-07	1.17e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	9.09e-07	1.16e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	8.77e-07	1.12e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	8.73e-07	1.11e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL6—Alzheimer's disease	8.49e-07	1.08e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	8.46e-07	1.08e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TP53—Alzheimer's disease	8.41e-07	1.07e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	8.38e-07	1.07e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	8.35e-07	1.07e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—AKT1—Alzheimer's disease	8.29e-07	1.06e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	8.28e-07	1.06e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TP53—Alzheimer's disease	8.26e-07	1.05e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	8.23e-07	1.05e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	8.21e-07	1.05e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PPARG—Alzheimer's disease	8.2e-07	1.05e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	8.13e-07	1.04e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	8.11e-07	1.03e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	8.09e-07	1.03e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	8.05e-07	1.03e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—INS—Alzheimer's disease	8.04e-07	1.03e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—AKT1—Alzheimer's disease	7.83e-07	1e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	7.71e-07	9.84e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL6—Alzheimer's disease	7.7e-07	9.83e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—AKT1—Alzheimer's disease	7.61e-07	9.71e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	7.58e-07	9.68e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL6—Alzheimer's disease	7.56e-07	9.65e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	7.54e-07	9.62e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	7.53e-07	9.62e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	7.51e-07	9.59e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	7.44e-07	9.5e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	7.42e-07	9.47e-06	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	7.11e-07	9.07e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7.05e-07	9e-06	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	6.99e-07	8.93e-06	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	6.98e-07	8.91e-06	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—AKT1—Alzheimer's disease	6.97e-07	8.9e-06	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	6.95e-07	8.88e-06	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	6.93e-07	8.85e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	6.89e-07	8.8e-06	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	6.86e-07	8.76e-06	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	6.85e-07	8.74e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	6.45e-07	8.23e-06	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	6.36e-07	8.12e-06	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—AKT1—Alzheimer's disease	5.26e-07	6.72e-06	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—AKT1—Alzheimer's disease	4.96e-07	6.33e-06	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.24e-07	4.14e-06	CbGpPWpGaD
